PIRAMAL PHARMA
Back to Income Statement
|
PIRAMAL PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹1,418 Cr | ₹1,171 Cr | ₹628 Cr | ₹950 Cr | ₹1,428 Cr |
What is the latest Operating Profit of PIRAMAL PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹1,418 Cr |
| Mar2024 | ₹1,171 Cr |
| Mar2023 | ₹628 Cr |
| Mar2022 | ₹950 Cr |
| Mar2021 | ₹1,428 Cr |
How is Operating Profit of PIRAMAL PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,418 Cr | 21.13 | |
| Mar2024 | ₹1,171 Cr | 86.32 | |
| Mar2023 | ₹628 Cr | -33.85 | |
| Mar2022 | ₹950 Cr | -33.50 | |
| Mar2021 | ₹1,428 Cr | - | |
Compare Operating Profit of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹22,186.1 Cr | 5% | -4.3% | -14.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 5% |
-4.3% |
-14.1% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses